... target used to treat all HIV patients, which could eventually lead to a new class of AIDS drugs. Researchers at the University of Michigan used computer models to develop the inhibiting compound, and ...
... have developed what they believe is the first new mechanism in nearly 20 years for inhibiting a common target used to treat all HIV patients, which could eventually lead to a new class of AIDS drugs.
... When Abbott Laboratories Inc. hiked up the price of a popular AIDS drug by 400 percent in 2003, executives prepared for the inevitable public relations hit, but assured themselves the ...
... cured and no longer need today's AIDS drugs for a lifetime. "There's a big hole in current ... human immunodeficiency virus), the virus that causes AIDS, there's an unsolved problem with current anti-viral ...
... online in the journal PLoS Pathogens, the team is searching for new drugs that may someday allow infected people to be cured and no longer need today's AIDS drugs for a lifetime...
BEIJING, Jan. 20 (UPI) -- Chinese health officials said new AIDS drugs will be distributed to combat resistance to first-line anti-retroviral drugs.
LONDON (AP) -- United Nations health officials estimate about 4 million people who need AIDS drugs worldwide are now getting them, according to a report issued Wednesday....
GENEVA, Switzerland, June 4 (UPI) -- The World Health Organization says nearly 3 million people with AIDS are now receiving anti-retroviral HIV drugs.
The agency said patients with a variation in an immune system gene should not be given the drug abacavir because they are at a far higher risk of a severe allergic reaction.
... be particularly effective at producing neurons (nerve cells) which can be used in laboratory testing for drugs for brain disorders such as Alzheimer's Disease and Parkinson's Disease.
In contrast, ...
... of Illinois at Chicago may have found a faster, cleaner, "greener" way to synthesize N-heterocycles, nitrogen-containing structures at the heart of almost all of the top 200 brand-name drugs.
... transmission prophylaxis program using nevirapine (an anti-AIDS drug) was not implemented, the authors write. The paper ... lost due to premature death from HIV/AIDS. The team chose a limited time period ...
WASHINGTON, Oct. 29 (UPI) -- The U.S. Food and Drug Administration has tentatively approved the 75th anti-retroviral generic drug of the president's emergency plan for AIDS relief.
... a new technology which can dramatically improve the effectiveness of antibacterial treatments. Drugs with the ability to dissolve have much stronger efficacy, however many drugs are insoluble. In ...
An investigation has found no evidence that any New York City foster children died as a result of their participation in clinical drug trials for H.I.V. and AIDS.
